Clinical Trial Update: PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma [NA]

View source ↗

Summary

This clinical trial update describes PDAC-PATHWAYS, a digital informational and supportive care app for patients initiating neoadjuvant therapy for pancreatic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: PDAC - Pancreatic Ductal Adenocarcinoma | NA | Status: RECRUITING